Summary: Determination of homocysteine in plasma or serum for evaluation of cobalamin and folate deficiency is becoming an important diagnostic procedure. Accurate, rapid and low cost methods for measuring homocysteine are therefore required. We have improved an HPLC method and made it suitable for clinical application. The more important changes are the addition of an internal Standard, mercaptopropionylglycine, and the use of a plasma/serum based calibration material. The method consists of the following steps: reduction of the sample with tri-H-butylphosphine, precipitation of proteins, derivatisation with ammonium 7-fluorobenzo-2-oxa-l,3-diazole-4-sulphonate, and HPLC Separation followed by fluorescence detection. The linearity of the assays is established and the coefficient of Variation is 3.0%. Stability studies show that blood samples must be cooled or centrifuged immediately after venipuncture. The method is useful for evaluation of cobalamin or folate deficiency, especially in patients with normal or moderately depressed cobalamin or folate concentrations in blood.
Introduction
*™<>/ f^ u * · · i · j About 70% of the homocysteine in plasma is reported Homocysteine is intimately related to methionine me-to be boünd to albumin (l, 2) and a variable amount tabolism. It constitutes a link between the transmeth-is present äs mixed disulphides. To measure the total ylation cycle where homocysteine is remethylated to homocysteine content (i. e., the sum of free homocymethionine and the transsülphuratiön pathway which steine and disulphide-bound homocysteine) the catabolises homocysteine to sulphate. Cobalamin and plasma/serum sample is reduced with tri-w-butylphosfolate defiency results in impaired homocysteine re-phine before protein precipitation. The content of free methylation and homocysteinaemia. The increasing homocysteine can be measured by performing the interest in measuring homocysteine is related to its reduction Step after protein precipitation. correlation to the cobalamin and folate Status in patients deficieiit in pne of these $ubstances, and also to its presumed role in arteriosclerotic cerebrovascular Materials and Methods diseases. Recently, these and other subjects related to Reagents homocysteine in plasma were reviewed by Ueland & Ammonium 7-fluorobenzo-2-oxa-l,3-diazole-4-sulphonate was Refsum (1) .
obtained from Wako (Kyoto, Japan); Z)L-homocysteine, mercaptopropionylglycine and tri-w-butylphosphine was from Öuf method can be used in any laboratory equipped Sigma (St. Louis, MO, U. S, A.); cysteine and glutathione was with an HPLC System, and all reagents are commer- 
Chromatographie conditions
We used the gradient procedures described by Araki & Sako (2) . Although our column and HPLC System differs from theirs and we observe shorter retention times, the procedures work satisfactorily.
Buffer A: 0.1 mol/1 acetate buffer, pH 4.0, containing 20 ml/l methanol (prepared from 0.1 mol/1 acetic acid and 0.1 mol/1 sodium acetate, approximately 600/1500).
Buffer B: 0.1 mol/1 phosphate buffer, pH 6.0, containing 50 ml/l methanol (prepared from 0.1 mol/1 sodium dihydrogen phosphate and 0.1 mol/1 disodium hydrogen phosphate, approximately 625/125).
The buffers were filtered through a 0.45 μπι Millipore filter. The linear gradient was run from solvent A to solvent B over 12.5 min (then 2.5 min B, a 3.0 min gradient back to A, and 2.0 min A Ipefore the next injection) at a flpw rate of 1.00 ml/ min. We also used an isocratic System, which was run for 20 min with solvent A at a flow rate of 1.00 ml/min.
Sample preparation
Plasma samples were obtained from about 3 ml of whole blood, which were collected in a Venoject tube containing EDTA, then immediately cooled on ice and centrifuged s soon s possible at 3000 min" 1 (2000 g) for 10 min at room temperature. Serum was prepared from whole blood which was left to clot for 1 Λ -3 Α hour at room temperature, then centrifuged. Specimens were stored at 4 °C for analysis on the same day. Storage for longer periods was at -20 °C.
One hundred and fifty microlitres of plasma/serum (sample or calibration material) was mixed with 50 μΐ of buffer/standard (0 or 0.2 mmol/1 homocysteine, 0.2 mmol/1 mercaptopropionŷ lglycine in 0.1 mol/1 potassium borate, pH 9.5, containing 2 mmol/1 EDTA). Twenty microlitres of 100 ml/l tri-/2-butylphosphine in dimethylformamide were added, and the reduction allowed to proceed for 30 min at 4 °C. Samples were then mixed with 125 μΐ of 0.6 mol/1 perchloric acid, containing l mmol/1 EDTA, left at room temperature for 10 min, then centrifuged at 13 000 min" 1 (15 500 g) for 10 min. One hundred microlitres were taken from the middle of the supernatant and mixed with 200 μΐ of 2 mol/1 potassium borate, pH 10.5, containing 5 mmol/1 EDTA. Ammonium 7-fluorobenzo-2-oxa-l,3-diazole-4-sulphonate solution (100 μΐ) (1.0 g/l of 2 mol/1 potassium borate, pH 9.5) were added and the mixture incubated at 60 °C for 60 min. After cooling in an ice bath, the samples were ready for HPLC. Ten microlitres of derivatised sample were used for each injection.
Specimens
Blood was obtained in the morning from 16 apparently healthy volunteers (eight men and eight women, aged 25-60 years). All were in a good nutritional state with a normal protein intake. None took drugs.
To test for possible interference from drugs, we measured homoĉ ysteine in plasma samples from 60 patients who had received various analgesic, antiepileptic, cardioactive, antipsychotic, antibiotic or antineoplastic drugs.
Calibration and calculations
A two point calibration line was obtained from triplicate analysis of a plasma/serum pool, and of this pool spiked with 50 μιηοΐ/ΐ homocysteine. A linear regression line, with the added homocysteine s the abcissa and the ratio between the area of the homocysteine peak and the mercaptopropionylglycine peak s the ordinate, was calculated to determine the slope of the calibration line. The concentration'of homocysteine in the sana* ples was then determined by dividing the ratio between the area of the homocysteine peak and the mercaptopropionylglycine peak by the slope of the calibration line.
The plasma and serum pools were stored s aliquots at -20 °C. The homocysteine and the mercaptopropionylglycine Solutions were kept s 0.4 mmol/1 aliquots at -20 °C.
Results and Discussion
Optimizing the assay conditions
In this work we have improved a method published by Araki & Sako (2) and made it more suitable for routine clinical use, The most important changes are the use of a plasma/serum pool for calibration instead of the buffer, and the addition of an internal Standard. The use of a plasma/serurn pool is necessary because the slope in the buffer calibration is less than in the plasma/serum pool calibration. The addition of mercaptopropionylglycine s an internal Standard serves two p rposes, s a control of the derivatisation procedure and s a direct standardisation of the size of the homocysteine peak. If the internal Standard mercaptopropionylglycine is not added to the samples we find that the total imprecision of the method approximately doubles. Other technical changes are the use of 150 μΐ of sample instead of the 500 μΐ used by the previous method (2) and precipitation with perchloric acid instead of trichloroacetic acid. In our System, the use of perchloric acid instead of trichloroacetic acid gives a better Separation of the peaks. As mentioned, we also tried to run the samples with an isocratic System to check whether HPLC Systems not equipped with a gradient System can be used. The chrornatograms obtained in this way with buffer A only are very similar to those from a gradient run, but we have not checked the stability and the d rability of the column under these conditions for a longer period.
Specificity
Derivatisation of the plasma/serum samples with the thiol-specific reagent ammonium 7-fl orobeiizo^2-oxa-l,3-diazole-4-sulphonate (3) The homocysteine peak was identified by adding homocysteine to the sample and observing an increase of the symmetrical well-defined peak. In the same way, we identified the peak with a retention time of about 2.4 min s cysteine, and the peak at about 6.3 min s glutathione. By comparison with the original work of Araki & Sako (2) we tentatively identify the peak at about 4.3 min s cysteinyl-glycine.
When we analysed plasma samples from 60 patients who had received various drugs, the chromatograms did not reveal any interferences in the assay or the appeafance of new peaks.
Calibration
Calibration lines prepared by the analysis of homocysteine in 0.2 mol/1 potassium borate, pH 9.5, or in a plasma pool showed different slopes (15% difference). Calibration must therefore be performed with plasma/serum-based calibrators. This matrix effect could be due to the presence of proteins, ionic strength or some other spedes catalysing the derivatisation
Step. The Variation of the slope in different plasmas was also investigated; the greatest Variation was 4% and thus less than the difference between a plasma pool and the buffer.
Recovery and linearity
To investigate the recovery and linearity of the assay, we added different concentrations of homocysteine to both the plasma and serum pools. Homocysteine was added to a plasma pool so s to increase its concentration by 0,25, 50,100,200, 300,400 and 500 μπκ>1/1. Linear regression analysis of the results gave y = 0.0220 + 0.0124 χ with a correlation coefficient of 0.999, where y is the ratio of the homocysteine peak area divided by the mercaptopropionylglycine peak area and χ is the increase in homocysteine concentration. The same experiment with serum gave y = 0.1015 + 0.0136 χ with a correlation coefficient of 1.000. Addition of 0, 5, 10, 25, 50 and 100 μπιοΐ/ΐ to a plasma pool gave y = 11.65 + 0.823 χ with a correlation coefficient of 0.999, where y is the ratio of the homocysteine peak area and χ is the increase in homocysteine concentration.
Plasma and serum samples were also diluted 1.2, 1.5, 2, 3, 6 and 12 times and plotted with χ s the amount of sample and y s the homocysteine peak area divided by the mercaptopropionylglycine peak area. The resulting line is slightly curved s expected from the dilution of the samples with a buffer with a 15% lower standardisation slope.
If a patient sample contains so much homocysteine that the chromatogram response goes off the scale (in our System more than 500 μπιοΐ/ΐ), the injection sample can be diluted and chromatographed again and recalculated by using the area of the mercaptopropionylglycine peak multiplied by the dilution factor.
Detection limit
The sensitivity of the method when defined s a signal to noise ratio ^ 5 is at least 0.3 μιηοΐ/ΐ homocysteine. This value is in accordance with other HPLC methods for measuring homocysteine (3, 4). Araki & Sako (2) did not state a limit of detection for measuring total homocysteine.
Precision
The total imprecision of the method was determined by dividing a plasma sample into aliquots and determining the homocysteine concentration of each aliquot in duplicate over a period of four weeks. Vester and Rasmussen: Method for determination of homocysleine in plasma and scrum μιηοΐ/ΐ homocysteinc, n = 11). The within-run component of imprecision was 2.3%. Araki & Sako (2) did not report values which are directly comparable. Furthermore, we divided a sample pool into ten aliquots which were assayed in one run. The coefficient of Variation was 2.4% (mean = 10.94 μπιοΙ/1). The major part of the variability is thus in the within-run imprecision, implying a low day-to-day Variation.
The within-run imprecision of our method compares favourably with those reported for other HPLC assays for homocysteine in plasma, namely 2.9% (3), 5.0% (4), and 3.8% (5). This improvement is probably a result of the addition of the internal Standard. Mercaptopropionylglycine has a high chemical resemblance to homocysteine although the retention time for mercaptopropionylglycine is considerably higher than for the homocysteine peak.
Stability studies
We investigated the effect of incubation of whole blood at room temperature before Separation of plasma or serum from cells. As depicted in figure 2 , a fresh blood sample left at room temperature without centrifugation will show a considerable increase in homocysteine concentration. This increase is linear for at least 4 hours and amounts to 9 -10% per hour. The relative increase after 24 hours varies significantly from sample to sample. This increase in homocysteine concentration can be eliminated by centrifugation followed by pipetting of plasma/serum. After centrifugation and pipetting the concentrations of homocysteine in the samples are stable, even at room temperature, for at least 24 hours. Therefore, the blood samples must be cooled or centrifuged immediately after blood sampling.
We stored plasma/serum samples at -20 °C for three months without any measurable change in the homocysteine concentrations. Furthermore, one sample was thawed and frozen nine times during one week and each time an aliquot was removed and frozen. When all samples were analysed in the same run, the homocysteine concentration was' 9.64 ± 0.19 μιηοΐ/ΐ (mean ± SD) and the first and last values were 9,67 and 9.51, respectively.
The samples are also very stable after derivatisation with ammonium 7-fluorobenzo-2-oxa-l,3-diazole-4-sulphonate. They can be stored at 4°C for several weeks. The samples may turn yellow because ammonium 7-fluorobenzo-2-oxa-l ,3-diazole-4-sulphonâ te is light sensitive. However, this does not seem to cause any problems in the assay, but s a precaution we kept the ammonium 7-fluorobenzo-2-oxa-l,3-diazole-4-sulphonate solution in a cold and dark place until use.
We did not filter the samples before injection into the column because we found it more economical (both in materials -the cost of one guard column equals the cost of 20 filters -and working hours) to change the small guard columns after abo t 75 sample injections.
The high increase of homocysteine in plasma/serum when blood samples are left at room temperature is an interesting problem. Cooling of the blood sample followed by incubation at room temperatures does not stop the increase of homocysteine in plasma/ serum. We measured the homocysteine concentration in haemolysates of bloocl and in isotonic NaCl ineubated with the residue of blood samples after removal of plasma. These preliminary experiments indicate that the homocysteine increase stems from a produc- The only single work of its kind in English, the Concise Encyclopedia of Biochemistry provides a comprehensive, yet compact, source of biochemical data and Information for the researcher, teacher, and Student. Following a five-year program of collecting and editing new material, äs well äs the revision of existing entries, the author-editors and the publishers are pleased to announce the new expanded Second Edition of this valuable reference work. Major entries concerning the latest developments in DNA stfucture, synthesis, sequencing, binding proteins and methods, oncogenes, lymphokines and other newly discovered regulatory peptides, structural proteins, inositol phosphates, and prötein kinases have been added. Graphic Illustration has been given high priority, so that regulatory processes, transport, subcellular structures, etc. are abundantly and clearly illustrated. The coverage of plant biochemistry has also been greatly expanded. Anöther new addition is a section on buffers which will be useful to anyone involved in laboratory work. Because of its comprehensiveness and multidisciplinary nature, we are sure that you will find it an indispensable reference tool. Contemporaries and coworkers together with other outstanding scientists describe the state of biochemistry in major fields: äs it was, äs it is now, and where it will be going. At the same time this volume is a reference book on Fritz Lipmann, the outstanding biochemist, and life scientist, who considered his concept of the energy-rich bond, symbolized by the squiggle, äs his major achievement. 
Practicability
Whether it is preferable to use plasma or serum is very dependent on the laboratory routines. We prefer to use plasma, because although serurn can be used if the reference r nge for healthy individuals is adjusted to it (tab. 1), it is impractical to keep control of the clotting time and the following centrifugation. The plasma method requires "a glass of ice at the bedside" and although this is inconvenient it is manageable.
Tab. l. Homocysteine concentration in μιηοΐ/ΐ, analysed in plasma and serum obtained from the same venipuncture. n = 8 for both men and women. About 50 tubes (calibrators + 22 samples in duplicate) can easily be processed in one working day and the samples can be analysed overnight. Use of the assay for six months pr vided it to be a robust and effective method, suitable for routine analysis.
We also used the method to determine free homocysteine in two samples (by precipitating the proteins before reduction with tri^butylph sphine). The samples showed a free homocysteine coutent of 1.6 μιηοΐ/ΐ and 1.7 μήιόΐ/ΐ homocysteine (6.1 μϊτιοΐ/ΐ and 6.9 μιηόΙ/1 in total homocysteine) which compare well with the values reviewed by Ueland & Refsum (1) .
Analysed blood samples
Plasma/serum homocysteine concentrations were naeasured in blood samples from 16 apparently healthy vplunteers. The plasma and the serum were obtained from the same venipuncture, and the homocysteine values were consistently higher (in average 10%) for all serum samples (p < 0.005, Wilcoxon test for pair diff rences). Most of this difference can be attributed to the different treatment of the blood samples, plasma samples being cooled immediately, whereas serum samples are left to clot at room temperature for 1 A - 3 A h before centrifugation.
The homocysteine r nge has been reported to differ between men and women ( s illustrated by the values below) but also to be age-dependent; for further details see 1. c. (1) . In general, men seem to have higher concentrations of homocysteine than women, while older people have higher concentrations than younger people. Our data, which are summarized in table l, support this difference between the homocysteine values in men and women (p < 0.005, Wilcoxon test for two samples). Our values are a little higher than those reported by Araki & Sako (2) who found 6.53 ± 1.08 μιηοΐ/ΐ homocysteine (mean ± SD) for men (n = 20), and 5.71 ± 1.20 for women (n = 15), while they are a little lower than the values reported by Brattstr m et al. (6) who reported 12.1 ± 4.0 for men (n = 22) and 8.9 ±1.0 for women (n = 10). Even higher values (7.2-21.7 μιηοΐ/ΐ homocysteine (mean + 2 SD), 20% higher in males than in females) have been reported for serum samples (7). These differences can probably be explained by the different handling of the blood samples before Separation of plasma and serum from cells and the various analytical methods employed.
Finally, in plasma samples of two patients with depressed concentrations of erythrocyte folate (188 and 301 nmol/1 respectively; reference r nge: 400 -1200 nmol/1) we found increased concentrations of plasma homocysteine, namely, 60.6 and 48.1 μιηοΐ/ΐ.
Conclusion
We have improved a method for measuring total homocysteine in plasma and serum. The method uses only commercially available reagents and requires only a Standard HPLC apparatus equipped with a fluorescence detector in addition to normal laboratory equipment. The addition of an internal Standard ensures good precision, accuracy and performance. The analysis is robust, fast and inexpensive and is now suitable for routine use in the clinical laboratory.
